openPR Logo
Press release

Eating Fruit Every Day Can Reduce The Risk of Developing Type 2 Diabetes

Eating Fruit Every Day Can Reduce The Risk of Developing Type 2

Eating at least two serves of fruit daily has been linked with 36 percent lower odds of developing type 2 diabetes, a new Edith Cowan University (ECU) study has found.

The study, published today in the Journal of Clinical Endocrinology and Metabolism, revealed that people who ate at least two serves of fruit per day had higher measures of insulin sensitivity than those who ate less than half a serve.

Type 2 diabetes is a growing public health concern with an estimated 451 million people worldwide living with the condition. A further 374 million people are at increased risk of developing type 2 diabetes.

The study's lead author, Dr Nicola Bondonno from ECU's Institute for Nutrition Research, said the findings offer fresh evidence for the health benefits of fruit.

"This is important because high levels of circulating insulin (hyperinsulinemia) can damage blood vessels and are related not only to diabetes, but also to high blood pressure, obesity, and heart disease.

"A healthy diet and lifestyle, which includes the consumption of whole fruits, is a great strategy to lower your risk of developing type 2 diabetes."

Fresh is best
The study examined data from 7,675 Australians participating in the Baker Heart and Diabetes Institute's AusDiab Study and assessed fruit and fruit juice intake and the prevalence of diabetes after five years.

Dr Bondonno said they did not observe the same beneficial relationship for fruit juice.

"Higher insulin sensitivity and a lower risk of diabetes was only observed for people who consumed whole fruit, not fruit juice," she said.

"This is likely because juice tends to be much higher in sugar and lower in fibre."

Dr Bondonno said that it's still unclear exactly how fruit contributes to insulin sensitivity, but it is likely to be multifaceted.

"As well as being high in vitamins and minerals, fruits are a great source of phytochemicals which may increase insulin sensitivity, and fibre which helps regulate the release of sugar into the blood and also helps people feel fuller for longer," she said.

"Furthermore, most fruits typically have a low glycaemic index, which means the fruit's sugar is digested and absorbed into the body more slowly."

The study builds on Dr Bondonno's research into the health benefits of fruit and vegetables, particularly those that contain a key nutrient known as flavonoids. The research is part of ECU's Institute of Nutrition Research.

Huateng Pharma is worldwide known for a variety of pharmaceutical intermediates used in research and development. We can provide antidiabetic drugs intermediates such as semaglutide intermediates, liraglutide intermediates, Alogliptin intermediates, Sitagliptin intermediates and Linagliptin intermediates for your research. We have our own factory and make scale-up production with capacities varying from gram to kilograms and multi tons.

Hunan Huateng Pharmaceutical Co. Ltd.
Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China
Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China
Email: sales@huatengusa.com
Website: https://us.huatengsci.com
Zip code: 410205
Telephone: +86 731 89916275
Fax: +86 0731-82251112-818

Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We are committed to providing cost-effective pharmaceutical products and services to customers around the world with the belief of “Strive for the Human Health".

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Eating Fruit Every Day Can Reduce The Risk of Developing Type 2 Diabetes here

News-ID: 2535645 • Views: 247

More Releases from Hunan Huateng Pharmaceutical Co. Ltd.

Huateng Pharma Develops Systemic Antiparasitic Agent Fluralaner
Fluralaner is a systemic insecticide and acaricide that can be administered orally or topically. Bravecto is the trade name. The U.S. Food and Drug Administration (FDA) approved it for flea treatment in dogs under the trade name Bravecto in May 2014 and for topical treatment in cats in November 2019. Fluralaner is a novel isooxazoline broad-spectrum insecticide that acts on γ-aminobutyric acid (GABA) receptors and has good activity against ticks, fleas,
Huateng Pharma Develops Intermediates of Carfilzomib For Multiple Myeloma
Carfilzomib, a proteasome inhibitor, is indicated for the treatment of patients with multiple myeloma. Multiple myeloma (multiple myeloma, MM) is a malignant tumor originating from the B cell lineage, characterized by the clonal proliferation of malignant plasma cells in the bone marrow microenvironment, causing fractures and bone marrow failure, and is the second most common blood system disease in the world Tumors cannot be cured by traditional chemotherapy regimens. Bortezomib is the
Huateng Pharma Develops Intermediates of Semaglutide For TD2
According to the latest IDF Diabetes map, the global prevalence of diabetes reached 10.5% in 2021, with 537 million adults living with diabetes. China has become a disaster zone for diabetes, with the largest number of adults with diabetes in the world. In the past 10 years (2011-2021), the number of people with diabetes in China increased from 90 million to 140 million, an increase of 56%. The total number
The Future of Treatment For Type 2 Diabetes
Although the treatment of type 2 diabetes (T2DM) has made impressive progress in the past few decades, researchers are constantly searching for new treatments. How to better control blood glucose and reduce diabetes-related complications has become a hot topic in the field of T2DM research. Previously, The Lancet Diabetes Endocrinology published an in-depth review detailing novel therapeutic targets for T2DM, mechanisms of drug action, and corresponding hypoglycemic efficacy. It involves innovation

All 5 Releases


More Releases for Eating

Eating Disorders Therapeutics Pipeline Analysis 2017
Eating disorders are disorders that can cause serious and fatal illness in the body. There are several types of eating disorders such as anorexia nervosa, bulimia nervosa, emotional overeating, binge eating disorder, and others. People with anorexia nervosa consider themselves as overweight even when they are dangerously underweight. People with bulimia nervosa generally have frequent episodes of uncontrollable eating. Access Report Overview: https://www.psmarketresearch.com/market-analysis/eating-disorders-therapeutics-pipeline-analysis People with binge eating disorder generally have
Exploring "emo-eating"
While fear and aggression tend to curb our appetite, sadness and frustration seem to stimulate it. A project funded by the Austrian Science Fund FWF looks into the connections between mood and overeating in healthy and bulimic individuals. We know how it feels to look forward to our favourite dish; we are familiar with the notions of comfort food and feeling butterflies in the stomach instead of hunger. In eating
Childhood Stress is Rising, Eating Recovery Center Offers Insight to Help Preven …
Center cites the connection between rising anxiety and stress-initiated mental illnesses as likely factor driving increased child and adolescent treatment inquiries Denver, Colo, January 29, 2013 – Stress among children and adolescents is on the rise, and mental health professionals are seeing the impact as more families seek treatment for their children and adolescents to address stress-initiated behavioral illnesses such as eating disorders. At Eating Recovery Center, an international center
2012 Eating Recovery Center Foundation Eating Disorders Conference Features Nati …
Registration Now Open for Educational Conference for Professionals Showcasing Innovative Eating Disorders Treatment Strategies, Highlighting Trends and Addressing Upcoming Changes in the Field Denver, CO, July 03, 2012 - Denver, Colo., has emerged as a national hub for the treatment of eating disorders. This August, the experts who elevated Denver to this status, along with a group of other highly regarded professionals, will gather in the Mile High City to share
Demand for Child and Adolescent Eating Disorders Care Prompts Eating Recovery Ce …
International Center for Eating Disorders Recovery Expands Partial Hospitalization Program for Children and Adolescents to Address Rising Incidence of Eating Disorders in Young Patient Populations Denver, CO, May 30, 2012 - In response to an increasing demand for child and adolescent eating disorders care, Eating Recovery Center, an international center for eating disorders recovery, has expanded its Partial Hospitalization Program for Children and Adolescents. With the opening of a new facility
11-04-2011 | Health & Medicine
CSG PR
Eating Disorders Treatment Award Named in Honor of Eating Recovery Center’s Dr …
Center’s Chief Clinical Officer Honored by National Eating Disorders Association for Outstanding Contributions to the Eating Disorders Field Denver, CO, November 02, 2011 - Nationally recognized eating disorders expert, Craig Johnson, PhD, FAED, CEDS, has been honored by the National Eating Disorders Association (NEDA), with the creation of a prestigious professional award in his name. The “Craig Johnson Award for Excellence in Clinical Practice and Training,” which was awarded for the